Fosun Diagnostics Obtains China Approval for SARS-CoV-2 Anti

The kit detects the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs within seven days of infection for patients with respiratory and fever symptoms.

Related Keywords

China , Germany , Australia , Fosun Pharma , China National Medical Products Administration , European Union , Institute For Drugs , Shanghai Fosun Pharmaceutical , National Medical Products Administration , Fosun Diagnostic , Novel Coronavirus , Antigen Detection Kit , Colloidal Gold , Fosun Diagnostics , Federal Institute , Medical Devices , Fosun Diagnostic Novel Coronavirus ,